Marinus Pharma (MRNS) Tops Q1 EPS by 31c

Marinus Pharma (NASDAQ: MRNS) reported Q1 EPS of ($0.52), $0.31 better than the analyst estimate of ($0.83). Revenue for the quarter came in at $14.19 million versus the consensus estimate of $2.28 million.

For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MIND Technology (MIND) Misses Q1 EPS by 5c
• Investing.com’s stocks of the week